Gilteritinib hemifumarate
Product Specifications
CAS Number
1254053-84-3
Target
FLT|||TAM Receptor
Related Pathways
Tyrosine Kinase/Adaptors|||Angiogenesis
Purity
0.9978
Bioactivity
Gilteritinib hemifumarate (ASP2215 hemifumarate) is a potent ATP-competitive dual FLT3 (IC50: 0.29 nM) and AXL (IC50: 0.73 nM) inhibitor for the treatment of relapsed or refractory FLT3 mutant AML.
Smiles
C(=C/C(O)=O)\C(O)=O.N(C=1C(C(N)=O)=NC(CC)=C(NC2CCOCC2)N1)C3=CC(OC)=C(C=C3)N4CCC(CC4)N5CCN(C)CC5
Molecular Formula
C29H44N8O3.1/2C4H4O4
Molecular Weight
610.75
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
130267-ML550 100 µL
NEIL2 (Endonuclease 8-like 2, DNA Glycosylase/AP Lyase Neil2, DNA- (apurinic or apyrimidinic site) Lyase Neil2, Endonuclease VIII-like 2, Nei Homolog 2, Nei-like Protein 2, FLJ31644, MGC2832, MGC4505, NEH2, NEI2) (MaxLight 550)
Ask
View Details 
C2415-55P-ML750 100 µL
CD62p (LECAM, P-Selectin, Endothelial Leukocyte Adhesion Molecule) (MaxLight 750) discontinued
Ask
View Details